Profund Advisors’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.05M | Buy |
19,074
+7,515
| +65% | +$415K | 0.04% | 289 |
|
|
2025
Q1 | $559K | Sell |
11,559
-9,090
| -44% | -$440K | 0.02% | 435 |
|
|
2024
Q4 | $797K | Buy |
20,649
+566
| +3% | +$21.8K | 0.03% | 343 |
|
|
2024
Q3 | $904K | Buy |
20,083
+5,554
| +38% | +$250K | 0.03% | 346 |
|
|
2024
Q2 | $503K | Sell |
14,529
-22,946
| -61% | -$795K | 0.02% | 492 |
|
|
2024
Q1 | $1.08M | Buy |
37,475
+9,585
| +34% | +$277K | 0.04% | 339 |
|
|
2023
Q4 | $640K | Sell |
27,890
-30,826
| -53% | -$707K | 0.03% | 441 |
|
|
2023
Q3 | $979K | Buy |
58,716
+6,933
| +13% | +$116K | 0.05% | 288 |
|
|
2023
Q2 | $1.43M | Buy |
51,783
+22,983
| +80% | +$635K | 0.08% | 224 |
|
|
2023
Q1 | $662K | Buy |
+28,800
| New | +$662K | 0.04% | 419 |
|